S. Halperin

发表

Is ‘conflict of interest’ a Misnomer? Managing interests in immunization research and evaluation

N. Crowcroft, E. McClymont, J. Brophy, 2021, Human vaccines & immunotherapeutics.

Exploring the impact of media and information on self-reported intentions to vaccinate against COVID-19: A qualitative interview-based study

S. Halperin, J. Parsons Leigh, K. Fiest, 2022, Human vaccines & immunotherapeutics.

Respiratory macrophages regulate CD4 T memory responses to mucosal immunization with recombinant adenovirus-based vaccines

R. Schwendener, S. Halperin, Z. Xing, 2016, Cellular Immunology.

Understanding Vaccine Hesitancy in Canada: Results of a Consultation Study by the Canadian Immunization Research Network

H. Witteman, K. Wilson, J. Heffernan, 2016, PloS one.

Group A Streptococcus CHANGING PATTERNS IN DISEASE MANIFESTATIONS

S. Halperin, J. Baker, 2014 .

Abscess at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

E. Rothstein, W. Walop, S. Halperin, 2007, Vaccine.

Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial.

O. Vanderkooi, G. Zuccotti, F. Martinón-Torres, 2019, Vaccine.

The Impact of Childhood Meningococcal Serogroup C Conjugate Vaccine Programs in Canada

S. Halperin, J. Bettinger, R. Tsang, 2009, The Pediatric infectious disease journal.

Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlers

S. Halperin, F. Diaz-Mitoma, P. Dull, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Randomized Controlled Trial of Dose Response to Influenza Vaccine in Children Aged 6 to 23 Months

D. Skowronski, S. Halperin, B. Ward, 2011, Pediatrics.

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children.

J. Treanor, S. Halperin, M. Germain, 2002, Vaccine.

Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia

H. Marshall, S. Halperin, K. Top, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada.

S. Halperin, K. Top, J. Bettinger, 2013, Vaccine.

Acellular vaccines for preventing whooping cough in children.

S. Halperin, Linjie Zhang, S. Prietsch, 2014, The Cochrane database of systematic reviews.

The disulfide oxidoreductase SdbA is active in Streptococcus gordonii using a single C‐terminal cysteine of the CXXC motif

S. Halperin, A. Cohen, L. Davey, 2016, Molecular microbiology.

IS PERTUSSIS IMMUNE GLOBULIN EFFICACIOUS FOR THE TREATMENT OF HOSPITALIZED INFANTS WITH PERTUSSIS?: NO ANSWER YET

T. B. Waggener, S. Halperin, W. Vaudry, 2007, The Pediatric infectious disease journal.

Vaccination: the importance of herd immunity

S. Halperin, A. Doroshenko, 2007 .

Safety and Immunogenicity of 2 Mixed Primary Infant Immunization Schedules of Pentavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliomyelitis, and Haemophilus influenzae Type b Vaccines at 2, 4, and 6 Months of Age: A Randomized Controlled Trial

J. Langley, S. Halperin, S. Mcneil, 2012, The Pediatric infectious disease journal.

Epidemiology of Pertussis and Haemophilus influenzae type b Disease in Canada With Exclusive Use of a Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae type b Pediatric Combination Vaccine and an Adolescent-Adult Tetanus-Diphtheria-Acellular Pertussis Vaccine: Impl

V. Waters, S. Halperin, J. Bettinger, 2009, The Pediatric infectious disease journal.

Mutation of the Streptococcus gordonii Thiol-Disulfide Oxidoreductase SdbA Leads to Enhanced Biofilm Formation Mediated by the CiaRH Two-Component Signaling System

S. Halperin, L. Davey, Song F Lee, 2016, PloS one.

Expression of the Streptococcus mutans essential two-component regulatory system VicRK is pH and growth-phase dependent and controlled by the LiaFSR three-component regulatory system.

Yung-Hua Li, S. Halperin, H. Lo, 2009, Microbiology.

Morbidity of pertussis in adolescents and adults.

S. Halperin, P. Déry, G. De Serres, 2000, The Journal of infectious diseases.

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.

D. Granoff, S. Halperin, N. MacDonald, 1998, JAMA.

The Epidemiology of Children Hospitalized With Herpes Zoster in Canada: Immunization Monitoring Program, Active (IMPACT), 1991–2005

S. Halperin, D. Scheifele, B. Tan, 2008, The Pediatric infectious disease journal.

The Effect of Funded Varicella Immunization Programs on Varicella-related Hospitalizations in IMPACT Centers, Canada, 2000–2008

S. Halperin, J. Bettinger, D. Scheifele, 2012, The Pediatric infectious disease journal.

Assessing the completeness of infant and childhood immunizations within a provincial registry populated by parental reporting: A study using linked databases in Ontario, Canada.

K. Wilson, A. Guttmann, K. Tu, 2020, Vaccine.

Childhood pertussis immunization status as reported by parents and the completeness of public-health and physician records in Nova Scotia.

S. Halperin, P. Duclos, A. Bentsi-Enchill, 1996, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Cost of Chickenpox in Canada: Part I. Cost of Uncomplicated Cases

S. Halperin, P. Déry, L. Ford-Jones, 1999, Pediatrics.

The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers

J. Langley, S. Halperin, D. Macdougall, 2015, BMJ Open.

Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study.

S. Halperin, M. Sadarangani, J. Bettinger, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study

S. Halperin, J. Kellner, E. Ford-Jones, 2002, The Pediatric infectious disease journal.

Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.

S. Trottier, M. Loeb, B. Light, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

HOSPITALIZATIONS FOR INVASIVE PNEUMOCOCCAL DISEASE AMONG HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTED CHILDREN , ADOLESCENTS AND YOUNG ADULTS IN THE UNITED STATES IN THE ERA OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY AND THE CONJUGATE PNEUMOCOCCAL VACCINE Athena

S. Halperin, J. Bettinger, L. Sauvé, 2010 .

Approved but non-funded vaccines: accessing individual protection.

N. Crowcroft, S. Halperin, B. Ward, 2014, Vaccine.

Hospitalization for Influenza A Versus B

S. Halperin, J. Bettinger, D. Tran, 2016, Pediatrics.

Cost effectiveness of infant vaccination for rotavirus in Canada.

D. Coyle, K. Coyle, S. Halperin, 2012, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Controlling serogroup B invasive meningococcal disease: the Canadian perspective

S. Deeks, S. Halperin, J. Bettinger, 2013, Expert review of vaccines.

Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.

S. Halperin, D. Scheifele, G. Predy, 2009, Vaccine.

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

J. Singer, Dianne Miller, J. Langley, 2013, JAMA.

Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know

J. Langley, S. Halperin, D. Macdougall, 2015, Human vaccines & immunotherapeutics.

A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response

O. Vanderkooi, J. Langley, A. Gruslin, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pertussis Immunization in the Global Pertussis Initiative North American Region: Recommended Strategies and Implementation Considerations

D. Greenberg, D. Skowronski, E. Rothstein, 2005, The Pediatric infectious disease journal.

197: Implementing Best Practices for Vaccination Pain Management

C. Chambers, M. Rieder, S. Halperin, 2014 .

Human challenge studies: a review of adequacy of reporting methods and results.

J. Langley, S. Halperin, Jennifer Kalil, 2012, Future microbiology.

The changing age and seasonal profile of pertussis in Canada.

D. Skowronski, S. Halperin, G. De Serres, 2002, The Journal of infectious diseases.

The control of pertussis--2007 and beyond.

S. Halperin, 2007, The New England journal of medicine.

CD43−, but not CD43+, IL-10-producing CD1dhiCD5+ B cells suppress type 1 immune responses during Chlamydia muridarum genital tract infection

A. Stadnyk, S. Halperin, J. Moore-Connors, 2014, Mucosal Immunology.

Conforming to ICMJE principles

S. Halperin, Brian Ward, D. Scheifele, 2005, Canadian Medical Association Journal.

Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada

J. Langley, S. Halperin, J. Bettinger, 2020, Emerging infectious diseases.

Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults

R. Das, S. Halperin, R. Rupp, 2017, The Journal of infectious diseases.

Use of a Chinese hamster ovary cell cytotoxicity assay for the rapid diagnosis of pertussis

S. Halperin, R. Bortolussi, A. Wort, 1990, Journal of clinical microbiology.

Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis

S. Halperin, R. Bortolussi, A. Wort, 1989, Journal of clinical microbiology.

Identification of Bordetella pertussis infection by shared-primer PCR

S. Halperin, D. Jansen, C. Manclark, 1994, Journal of clinical microbiology.

Evaluation of Adjuvanted Pandemic H1N12009 Influenza Vaccine After One and Two Doses in Young Children

O. Vanderkooi, J. Langley, S. Halperin, 2011, The Pediatric infectious disease journal.

Immunization in Canada: a success to build on

Robert Pless, S. Halperin, 2003 .

Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013

K. Forsyth, S. Halperin, S. Plotkin, 2015, The Pediatric infectious disease journal.

Maternal immunisation 1 Maternal immunisation: a worldwide landscape analysis [A: title edited to be more descriptive and explanatory]

V. Verhasselt, K. Edwards, A. Marchant, 2017 .

Maternal immunisation 1 Maternal immunisation : collaborating with mother nature

V. Verhasselt, K. Edwards, A. Marchant, 2017 .

Maternal immunisation: collaborating with mother nature.

V. Verhasselt, K. Edwards, A. Marchant, 2017, The Lancet. Infectious diseases.

Waning Vaccine Immunity and Vaccination Responses in Children Treated for Acute Lymphoblastic Leukemia: A Canadian Immunization Research Network Study

S. R. Rassekh, S. Halperin, K. Top, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults

R. Das, S. Halperin, B. Coller, 2019, The Journal of infectious diseases.

Surveillance for Influenza Admissions Among Children Hospitalized in Canadian Immunization Monitoring Program Active Centers, 2003–2004

T. Tam, S. Halperin, P. Déry, 2006, Pediatrics.

Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significance

J. Langley, S. Halperin, K. Top, 2020, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

Routine immunization of adults by pharmacists: Attitudes and beliefs of the Canadian public and health care providers

J. Langley, S. Halperin, J. Isenor, 2016, Human vaccines & immunotherapeutics.

Safety, immunogenicity, and tolerability of three influenza vaccines in older adults

M. Loeb, S. Halperin, J. Bettinger, 2013, Human vaccines & immunotherapeutics.

A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults

S. Halperin, M. Germain, Kevin R Clarke, 2005, Human vaccines.

Thiol-Disulfide Exchange in Gram-Positive Firmicutes.

S. Halperin, L. Davey, Song F Lee, 2016, Trends in microbiology.

Antibody response to bacteriophage hyaluronidase in acute glomerulonephritis after group A streptococcal infection.

E. Kaplan, S. Halperin, L. Wannamaker, 1987, The Journal of infectious diseases.

Effect of alcohol skin cleansing on vaccination-associated infections and local skin reactions: a randomized controlled trial

S. Halperin, A. Taddio, S. Ito, 2019, Human vaccines & immunotherapeutics.

Developing Better Paediatric Vaccines

S. Halperin, 1999, BioDrugs.

A Modified Vaccine Reduces the Rate of Large Injection Site Reactions to the Preschool Booster Dose of Diphtheria-Tetanus-Acellular Pertussis Vaccine: Results of a Randomized, Controlled Trial

D. Skowronski, S. Halperin, D. Scheifele, 2005, The Pediatric infectious disease journal.

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

J. Langley, S. Halperin, Laurence Fissette, 2016, The Journal of infectious diseases.

Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.

R. Hancock, G. Zhong, S. Halperin, 2012, Vaccine.

Trivalent MDCK cell culture-derived influenza vaccine Optaflu® (Novartis Vaccines)

S. Halperin, A. Doroshenko, 2009, Expert review of vaccines.

Heterogeneity of rotavirus testing and admitting practices for gastroenteritis among 12 tertiary care pediatric hospitals: Implications for surveillance.

S. Halperin, J. Bettinger, D. Scheifele, 2011, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Hospital acquired rotavirus infections: burden in Canadian paediatric hospitals

S. Halperin, J. Bettinger, D. Scheifele, 2011 .

Substantial Morbidity for Hospitalized Children With Community-Acquired Rotavirus Infections: 2005–2007 IMPACT Surveillance in Canadian Hospitals

S. Halperin, J. Bettinger, D. Scheifele, 2010, The Pediatric infectious disease journal.

Contact among healthcare workers in the hospital setting: developing the evidence base for innovative approaches to infection control

B. Pourbohloul, J. Langley, L. Johnston, 2018, BMC Infectious Diseases.

A randomized, controlled non-inferiority trial comparing A(H1N1)pmd09 vaccine antigen, with and without AS03 adjuvant system, co-administered or sequentially administered with an inactivated trivalent seasonal influenza vaccine

D. Vaughn, J. Langley, Ping Li, 2012, BMC Infectious Diseases.

Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.

J. Langley, S. Halperin, J. Graham, 2019, Vaccine.

Prevention of pertussis across the age spectrum through the use of the combination vaccines PENTACEL™ and ADACEL™

S. Halperin, 2006, Expert opinion on biological therapy.

The responses of Aboriginal Canadians to adjuvanted pandemic (H1N1) 2009 influenza vaccine

F. Aoki, S. Halperin, E. Rubinstein, 2011, Canadian Medical Association Journal.

Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial

W. J. Ramsey, T. Monath, J. Alimonti, 2017, Canadian Medical Association Journal.

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada

S. Trottier, M. Loeb, A. Chit, 2017, BMC Infectious Diseases.

Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.

R. Devlieger, I. Margarit, G. Grandi, 2018, The Journal of infection.

Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study.

H. Marshall, S. Halperin, K. Perrett, 2018, Vaccine.

Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp).

K. Jansen, S. Halperin, M. Sadarangani, 2020, Vaccine.

The challenge of post-implementation surveillance for novel meningococcal vaccines.

D. Medini, L. DeTora, E. Moxon, 2012, Vaccine.

Regulation of D-alanylation of lipoteichoic acid in Streptococcus gordonii.

S. Halperin, Song F Lee, N. McCormick, 2011, Microbiology.

BIOCINE® MENINGOCOCCAL C (MenC) CONJUGATE VACCINE ELICITS HIGH TITERS OF SERUM BACTERICIDAL ACTIVITY IN TODDLERS. ▴ 1053

D. Granoff, S. Halperin, N. MacDonald, 1996, Pediatric Research.

Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10–25 Years of Age

J. Langley, S. Halperin, S. Mcneil, 2013, Journal of the Pediatric Infectious Diseases Society.

Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial

R. Devlieger, S. Halperin, P. Dull, 2016, Obstetrics and gynecology.

Expression and purification of a trivalent pertussis toxin-diphtheria toxin-tetanus toxin fusion protein in Escherichia coli.

S. Halperin, M. Aminian, Song F Lee, 2007, Protein expression and purification.

Expression of diphtheria toxin in Streptococcus mutans and induction of toxin-neutralizing antisera.

C. W. Lee, S. Halperin, S. F. Lee, 2005, Canadian journal of microbiology.

Expression and Immunogenicity of a Recombinant Diphtheria Toxin Fragment A in Streptococcus gordonii

S. Halperin, Song F Lee, Chiang W. Lee, 2004, Applied and Environmental Microbiology.

Childhood immunization rates in Canada are too low: UNICEF.

S. Halperin, J. Bettinger, D. Scheifele, 2014, Paediatrics & child health.

The Disease Burden of Invasive Meningococcal Serogroup B Disease in Canada

S. Halperin, J. Bettinger, R. Tsang, 2013, The Pediatric infectious disease journal.

Purification and Immunogenicity of a Recombinant Bordetella pertussis S1S3FHA Fusion Protein Expressed by Streptococcus gordonii

S. Halperin, Song F Lee, J. Knight, 2002, Applied and Environmental Microbiology.

Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration.

K. Forsyth, J. Mertsola, S. Halperin, 2001, Vaccine.

Pertussis immunization in paediatric healthcare workers: knowledge, attitudes, beliefs, and behaviour.

S. Halperin, K. Top, D. MacKinnon-Cameron, 2010, Vaccine.

Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults

S. Halperin, D. Scheifele, Bruce Smith, 2000, The Pediatric infectious disease journal.

Pediatric combined formulation DTaP–IPV/Hib vaccine

S. Halperin, D. Scheifele, C. White, 2009, Expert review of vaccines.

Ongoing Control of Haemophilus influenzae Type B Infections in Canadian Children, 2004–2007

S. Halperin, J. Bettinger, R. Bortolussi, 2008, The Pediatric infectious disease journal.

Invasive Infections Caused by Haemophilus influenzae Serotypes in Twelve Canadian IMPACT Centers, 1996–2001

S. Halperin, J. Embree, D. Scheifele, 2007, The Pediatric infectious disease journal.

Pertussis Across the Globe: Recent Epidemiologic Trends From 2000-2013.

K. Forsyth, S. Halperin, S. Plotkin, 2015, The Pediatric infectious disease journal.

Exacerbations of asthma in adults during experimental rhinovirus infection.

P. Suratt, S. Halperin, J. Hendley, 1985, The American review of respiratory disease.

Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis.

L. Babiuk, R. Hancock, A. Potter, 2011, Vaccine.

Pertussis and influenza immunisation during pregnancy: a landscape review.

K. Edwards, S. Halperin, B. Abu Raya, 2017, The Lancet. Infectious diseases.

Bacterial cultures of the lower respiratory tract in normal volunteers with and without experimental rhinovirus infection using a plugged double catheter system.

P. Suratt, S. Halperin, J. Hendley, 1982, The American review of respiratory disease.

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007.

G. Tyrrell, S. Halperin, J. Bettinger, 2010, Vaccine.

Streptococcus pyogenes: Basic Biology to Clinical Manifestations: Current Approaches to Group A Streptococcal Vaccine Development.

Manisha Pandey, I. Margarit, G. Grandi, 2016 .

Invasive Pneumococcal Infections in Canadian Children

G. Tyrrell, S. Halperin, J. Bettinger, 2007 .

Oral colonization and immune responses to Streptococcus gordonii expressing a pertussis toxin S1 fragment in mice.

S. Halperin, A. Macarthur, Song F Lee, 2002, FEMS microbiology letters.

Carotid artery dissection as a possible severe complication of pertussis in an adult: clinical case report and review.

D. Skowronski, S. Halperin, J. Buxton, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults.

E. Mills, B. Hutton, D. Fergusson, 2008, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.

J. Langley, M. Reddish, S. Halperin, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses: Individual-Participant Data Meta-Analysis

S. Halperin, M. Sadarangani, N. Curtis, 2021, Frontiers in Immunology.

Implementation Effectiveness of a Parent-Directed YouTube Video (“It Doesn’t Have To Hurt”) on Evidence-Based Strategies to Manage Needle Pain: Descriptive Survey Study

C. Chambers, K. Birnie, S. Halperin, 2020, JMIR pediatrics and parenting.

Inadequate pain management during routine childhood immunizations: the nerve of it.

C. Chambers, M. Rieder, S. Halperin, 2009, Clinical therapeutics.

Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15-20-month-old toddlers.

J. Langley, S. Halperin, F. Diaz-Mitoma, 2006, Vaccine.

Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.

S. Halperin, F. Diaz-Mitoma, D. Radley, 2009, Vaccine.

Safety and Immunogenicity of Two Formulations of a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae b Conjugate-Hepatitis B Vaccine in 15 to 18 Month-Old Children

J. Langley, S. Halperin, D. Radley, 2005, Human vaccines.

Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.

S. Halperin, J. King, E. Mills, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age.

S. Halperin, D. Scheifele, Bruce Smith, 2006, Vaccine.

Safety and Immunogenicity of a Pentavalent Combination Vaccine (Diphtheria, Tetanus, Acellular Pertussis, Polio and Haemophilus Influenzae Type b Conjugate) When Administered as a Fourth Dose at 15 to 18 Months of Age

S. Halperin, F. Noriega, B. Tapiéro, 2005, Human vaccines.

Safety and Immunogenicity of a Toddler Dose Following an Infant Series of a Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b, Hepatitis B Vaccine Administered Concurrently or at Separate Visits With a Heptavalent Pneumococcal Conjugate Vaccin

S. Halperin, A. Tomovici, M. Dionne, 2013, The Pediatric infectious disease journal.

Outbreak of Atypical Pertussis Detected by Polymerase Chain Reaction in Immunized Preschool-Aged Children

V. Waters, S. Halperin, S. Richardson, 2009, The Pediatric infectious disease journal.

Invasive pneumococcal infections in Canadian children, 1998-2003: implications for new vaccination programs.

G. Tyrrell, S. Halperin, J. Bettinger, 2007, Canadian journal of public health = Revue canadienne de sante publique.

High-Level Immunogenicity Is Achieved With Adjuvanted Pandemic H1N1 2009 Vaccine and Improved With Booster Dosing in a Randomized Trial of HIV-Infected Adults

S. Walmsley, S. Halperin, C. Cooper, 2012 .

Immunogenicity Is Not Improved by Increased Antigen Dose or Booster Dosing of Seasonal Influenza Vaccine in a Randomized Trial of HIV Infected Adults

J. Singer, B. Conway, S. Walmsley, 2011, PloS one.

Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study.

S. Halperin, M. Sadarangani, J. Bettinger, 2022, Vaccine.

Influenza immunization practices and policies for health care students in Canada.

S. Halperin, B. Halperin, K. Pianosi, 2013, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women.

J. Langley, S. Halperin, D. Macdougall, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens.

S. Halperin, D. Scheifele, A. Ferguson, 2001, Vaccine.

Group B streptococcal testing during pregnancy: survey of postpartum women and audit of current prenatal screening practices.

S. Halperin, Bruce Smith, H. Scott, 2005, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adults.

J. Langley, S. Halperin, L. Fries, 2006, Vaccine.

Differential Activation of Dendritic Cells by Toll‐like Receptor Agonists Isolated from the Gram‐positive Vaccine Vector Streptococcus gordonii

S. Halperin, Song F Lee, S. F. Lee, 2009, Scandinavian journal of immunology.

Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial.

S. Halperin, Bruce Smith, J. Shay, 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Persistence of pertussis in an immunized population: results of the Nova Scotia Enhanced Pertussis Surveillance Program.

D. Maclean, S. Halperin, R. Bortolussi, 1989, The Journal of pediatrics.

Safety, immunogenicity, and tolerability of three influenza vaccines in older adults Results of a randomized, controlled comparison

M. Loeb, S. Halperin, Brian Ward, 2013 .

Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.

E. Rothstein, W. Walop, S. Halperin, 2004, Vaccine.

Pertussis--a disease and vaccine for all ages.

S. Halperin, 2005, The New England journal of medicine.

Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada.

S. Halperin, E. Ford-Jones, D. Moore, 2003, The Journal of pediatrics.

Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program--Active (IMPACT).

E. Wang, S. Halperin, P. Déry, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines.

S. Halperin, D. Scheifele, L. Barreto, 1999, The Journal of pediatrics.

Haemophilus Disease in Alaskan and Canadian Children

V. Waters, S. Halperin, J. Bettinger, 2010 .

Population-based epidemiology of invasive pneumococcal infection in children in nine urban centers in Canada, 1994 through 1998

S. Halperin, D. Scheifele, G. Bjornson, 2002, The Pediatric infectious disease journal.

The Effect of Changing From Whole-Cell to Acellular Pertussis Vaccine on the Epidemiology of Hospitalized Children With Pertussis in Canada

T. Tam, S. Halperin, J. Bettinger, 2007, The Pediatric infectious disease journal.

Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001–2003

S. Halperin, A. King, D. Scheifele, 2005, Canadian Medical Association Journal.

Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis

S. Halperin, T. Jones, G. Van Nest, 2006, Clinical and experimental immunology.

Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety.

S. Halperin, D. Scheifele, 2003, Seminars in pediatric infectious diseases.

Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT.

N. Barrowman, S. Halperin, D. Moore, 2003, Pediatrics.

Persistent crying in infants and children as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.

W. Walop, S. Halperin, J. Bonhoeffer, 2004, Vaccine.

Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age.

K. Reisinger, C. Gill, E. Walter, 2010, Vaccine.

Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada

O. Vanderkooi, E. Emini, W. Gruber, 2012, The Pediatric infectious disease journal.

Rapid diagnosis of pertussis using the chinese hamster ovary cell cytotoxicity assay

S. Halperin, A. Kasina, M. Swift, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

Infection of Newborn Piglets with Bordetella pertussis: a New Model for Pertussis

L. Babiuk, S. Elahi, V. Gerdts, 2005, Infection and Immunity.

Physician vaccination practices in mild to moderate inborn errors of immunity and retrospective review of vaccine completeness in IEI: results from the Canadian Immunization Research Network

S. Halperin, K. Top, M. Sadarangani, 2022, Allergy, Asthma & Clinical Immunology.

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults.

D. Skowronski, S. Halperin, Bruce Smith, 2000, Vaccine.

Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults.

J. Langley, F. Noya, S. Halperin, 2007, Vaccine.

Recommendation for an adolescent dose of tetanus and diphtheria toxoids and acellular pertussis vaccine: reassurance for the future.

S. Halperin, 2006, The Journal of pediatrics.

How Soon After a Prior Tetanus-Diphtheria Vaccination Can One Give Adult Formulation Tetanus-Diphtheria-Acellular Pertussis Vaccine?

Mitchell Zelman, M. Decker, S. Halperin, 2006, The Pediatric infectious disease journal.

Canadian Experience With Implementation of an Acellular Pertussis Vaccine Booster-Dose Program in Adolescents: Implications for the United States

S. Halperin, 2005, The Pediatric infectious disease journal.

Pertussis immunization for adolescents: What are we waiting for?

S. Halperin, 2001, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Pertussis immunization for adolescents: What are we waiting for?

S. Halperin, 2001, Paediatrics & child health.

Acellular vaccines for preventing whooping cough in children.

S. Halperin, Linjie Zhang, S. Prietsch, 2012, The Cochrane database of systematic reviews.

Immunogenicity of a five-component acellular pertussis vaccine in infants and young children.

S. Halperin, L. Barreto, B. Friesen, 1994, Archives of pediatrics & adolescent medicine.

Cellular Immunity as a Potential Cause of Local Reactions to Booster Vaccination With Diphtheria and Tetanus Toxoids and Acellular Pertussis Antigens

S. Halperin, D. Scheifele, J. Ochnio, 2009, The Pediatric infectious disease journal.

An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed com

J. Langley, S. Halperin, A. Tomovici, 2007, Vaccine.

Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities.

S. Halperin, B. Law, B. Eastwood, 1994, Archives of pediatrics & adolescent medicine.

Current practices of adjunctive therapy for pertussis at six Canadian tertiary care pediatric hospitals.

C. Naugler, S. Halperin, 1998, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Epitope specificity of three anti-pertussis toxin monoclonal antibodies with dissimilar effects in assays of toxin neutralizing activity.

S. Halperin, T. Issekutz, A. Kasina, 1991, Molecular immunology.

The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or an associated complication.

S. Halperin, P. Déry, R. Gold, 2000, The Pediatric infectious disease journal.

Nonhuman primate and human challenge models of pertussis.

T. Merkel, S. Halperin, 2014, The Journal of infectious diseases.

Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selection.

S. Halperin, J. Bettinger, R. Tsang, 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose.

J. Langley, F. Noya, M. Decker, 2012, Vaccine.

Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous dose.

J. Langley, F. Noya, S. Halperin, 2011, Vaccine.

Role of the Cell Wall Microenvironment in Expression of a Heterologous SpaP-S1 Fusion Protein by Streptococcus gordonii

S. Halperin, Elisabeth M. Davis, Song F Lee, 2010, Applied and Environmental Microbiology.

Role of d-Alanylation of Streptococcus gordonii Lipoteichoic Acid in Innate and Adaptive Immunity

S. Halperin, Elisabeth M. Davis, Song F Lee, 2007, Infection and Immunity.

Role of surface proteins SspA and SspB of Streptococcus gordonii in innate immunity.

S. Halperin, Jun Wang, Song F Lee, 2012, Microbiology.

Deficient Priming Activity of Newborn Cord Blood–Derived Polymorphonuclear Neutrophilic Granulocytes with Lipopolysaccharide and Tumor Necrosis Factor-α Triggered with Formyl-Methionyl-Leucyl-Phenylalanine

S. Halperin, R. Bortolussi, K. Rajaraman, 1993, Pediatric Research.

Surface Expression of a Protective Recombinant Pertussis Toxin S1 Subunit Fragment in Streptococcus gordonii

S. Halperin, Song F Lee, G. Faulkner, 1999, Infection and Immunity.

Pertussis immunization during pregnancy: a review of the evidence and gap analysis

S. Halperin, D. Scheifele, Bahaa Abu Raya, 2017 .

Low pertussis toxin antibody levels in two regional cohorts of Canadian pregnant women.

S. Halperin, J. Isaac-Renton, M. Bigham, 2014, Vaccine.

The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.

S. Halperin, M. Sadarangani, J. Bettinger, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Changing pattern of clinical illness in children with group A streptococcal bacteremia.

S. Halperin, R. Bortolussi, M. Swift, 1993, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Lyme disease vaccine.

S. Halperin, 2000, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study.

J. Langley, S. Halperin, S. Mcneil, 2019, Vaccine.

Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines.

K. Edwards, M. Decker, S. Halperin, 1992, The Journal of pediatrics.

Lack of Evidence of Encephalopathy Related to Pertussis Vaccine : Active Surveillance by IMPACT, Canada, 1993–2002

S. Halperin, D. Moore, D. Scheifele, 2004, The Pediatric infectious disease journal.

The Immunization Monitoring Program-active (IMPACT) prospective surveillance of varicella zoster infections among hospitalized Canadian Children: 1991-1996.

S. Halperin, P. Déry, R. Gold, 2000, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Three-year follow-up of protection rates in children given varicella vaccine.

S. Halperin, F. Diaz-Mitoma, D. Scheifele, 2002, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Reactogenicity to a live attenuated varicella vaccine in Canadian children.

S. Halperin, F. Diaz-Mitoma, D. Scheifele, 2000, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Effectiveness of a whole cell pertussis vaccine in child-care centers and schools.

S. Halperin, P. Déry, G. De Serres, 1996, The Pediatric infectious disease journal.

Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.

S. Halperin, N. MacDonald, A. Izu, 2002, Clinical and investigative medicine. Medecine clinique et experimentale.

Antimicrobial products in the home : The evolving problem of antibiotic resistance

S. Halperin, J. Embree, R. Dobson, 2017 .

Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison

S. Halperin, T. Cyr, J. McElhaney, 2017, Human vaccines & immunotherapeutics.

Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: A case study of Nunavik, Canada

S. Moghadas, J. Langley, S. Halperin, 2021, EClinicalMedicine.

Assessing the risk of intussusception and rotavirus vaccine safety in Canada

K. Wilson, S. Hawken, J. Langley, 2016, Human vaccines & immunotherapeutics.

Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.

O. Vanderkooi, G. Zuccotti, F. Martinón-Torres, 2021, Vaccine.

Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine.

S. Halperin, E. Mills, B. Eastwood, 1997, Vaccine.

Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies.

L. Babiuk, R. Hancock, A. Potter, 2013, Vaccine.

Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets.

L. Babiuk, A. Potter, V. Gerdts, 2011, Vaccine.

A universal infant rotavirus vaccine program in two delivery models: Effectiveness and adverse events following immunization

J. Langley, C. Sanford, Mitchell Zelman, 2015, Human vaccines & immunotherapeutics.

Canada's first universal varicella immunization program: Lessons from Prince Edward Island.

S. Halperin, L. Sweet, P. Gallant, 2003, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Construction and Characterization of Single-Chain Variable Fragment Antibodies Directed against the Bordetella pertussis Surface Adhesins Filamentous Hemagglutinin and Pertactin

S. Halperin, Elisabeth M. Davis, Song F Lee, 2007, Infection and Immunity.

Construction and Characterization of Single-Chain Variable Fragment Antibodies Directed against the Bordetella pertussis Surface Adhesins Filamentous Hemagglutinin and Pertactin (cid:1)

S. Halperin, Elisabeth M. Davis, Song F Lee, 2007 .

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform

J. Langley, S. Halperin, M. Stanford, 2017, Human vaccines & immunotherapeutics.

Influenza Virus Vaccine Adjuvanted Pandemic H1N1 (2009) the Young Children following Two Doses of Unusual Patterns of IgG Avidity in Some

S. Halperin, B. Ward, Jyotsana Gupta, 2014 .

Unusual Patterns of IgG Avidity in Some Young Children following Two Doses of the Adjuvanted Pandemic H1N1 (2009) Influenza Virus Vaccine

S. Halperin, B. Ward, D. Scheifele, 2013, Clinical and Vaccine Immunology.

Estolate for the Treatment of Pertussis Azithromycin Is as Effective as and Better Tolerated Than Erythromycin

J. Langley, S. Halperin, F. Boucher, 2006 .

Invasive pneumococcal infections among Canadian aboriginal children.

S. Halperin, J. Kellner, D. Scheifele, 2003, Canada communicable disease report = Releve des maladies transmissibles au Canada.

A double-blind, randomized phase II trial of the safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults

J. Langley, M. Reddish, S. Halperin, 2006 .

Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).

D. Medini, S. Halperin, J. Bettinger, 2013, Vaccine.

Knowledge, attitudes, beliefs, and behaviors of pregnant women approached to participate in a Tdap maternal immunization randomized, controlled trial

J. Langley, S. Halperin, D. Macdougall, 2016, Human vaccines & immunotherapeutics.

Burden of Seasonal Influenza in Children With Neurodevelopmental Conditions

S. Halperin, J. Bettinger, D. Tran, 2014, The Pediatric infectious disease journal.

Children hospitalized with influenza during the 2006-2007 season: a report from the Canadian Immunization Monitoring Program, Active (IMPACT).

T. Tam, S. Halperin, J. Bettinger, 2008, Canada communicable disease report = Releve des maladies transmissibles au Canada.

High-Level Immunogenicity Is Achieved Vaccine With Adjuvanted Pandemic H1N12009 and Improved With Booster Dosing in a Randomized Trial of HIV-Infected Adults

S. Walmsley, S. Halperin, C. Cooper, 2012, HIV Clinical Trials.

Mucosal Immunization with a Genetically Engineered Pertussis Toxin S1 Fragment-Cholera Toxin Subunit B Chimeric Protein

S. Halperin, Song F Lee, A. Morris, 2003, Infection and Immunity.

Chimeric Protein Fragment-Cholera Toxin Subunit B Engineered Pertussis Toxin S 1 Mucosal Immunization with a Genetically

S. Halperin, Song F Lee, A. Morris, 2003 .

Expression, purification, and functional analysis of an antigen-targeting fusion protein composed of CD40 ligand and the C-terminal fragment of ovalbumin.

S. Halperin, Song F Lee, Yunnuo Shi, 2018, Protein expression and purification.

Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants

J. Langley, K. Ford, Ly-Mee Yu, 2009, The Pediatric infectious disease journal.

Prevention of perinatal group B streptococcal infection: Management strategies.

S. Halperin, N. Demianczuk, D. McMillan, 1997, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulations.

J. Langley, C. Gill, Ly-Mee Yu, 2012, Vaccine.

Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis Initiative

S. Halperin, C. Jones, U. Heininger, 2022, Vaccines.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

S. Trottier, M. Loeb, A. Chit, 2018, Vaccine.

Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation.

S. Halperin, U. Heininger, J. Bonhoeffer, 2007, Vaccine.

Safety and Immunogenicity of a Hexavalent Vaccine Administered at 2, 4 and 6 Months of Age With or Without a Heptavalent Pneumococcal Conjugate Vaccine: A Randomized, Open-label Study

S. Halperin, A. Tomovici, M. Dionne, 2013, The Pediatric infectious disease journal.

Immunologic Considerations for the Timing of the Booster Dose of 7-Valent Pneumococcal Conjugate Vaccine in Young Children

S. Halperin, D. Wortzman, D. Scheifele, 2007, The Pediatric infectious disease journal.

A single dose of an effective whole cell pertussis vaccine does not significantly increase protection in children primed with a less effective vaccine.

S. Halperin, G. De Serres, P. Duclos, 1999, Vaccine.

Serologic and Molecular Tools for Diagnosing Bordetella pertussis Infection

S. Halperin, 2006 .

The Safety and Immunogenicity of a Quadrivalent Measles, Mumps, Rubella and Varicella Vaccine in Healthy Children: A Study of Manufacturing Consistency and Persistence of Antibody

S. Klopfer, S. Black, S. Halperin, 2006, The Pediatric infectious disease journal.

Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age.

S. Halperin, D. Scheifele, B. Eastwood, 1999, The Pediatric infectious disease journal.

Review of pediatric encephalitis and encephalopathy cases following immunization reported to the Canadian Immunization Monitoring Program Active (IMPACT) from 1992 to 2012.

S. Halperin, K. Top, J. Bettinger, 2020, Vaccine.

Trends and characteristics of Tdap vaccination during pregnancy in Ontario, Canada: a retrospective cohort study

K. Wilson, S. Hawken, J. Cook, 2022, CMAJ open.

Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis.

S. Halperin, M. Sadarangani, N. Curtis, 2021, Vaccine.

Tdap vaccination in pregnancy

S. Halperin, Daniel Dalcin, 2021, Canadian Medical Association Journal.

A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study

J. Langley, B. Schepens, X. Saelens, 2018, The Journal of infectious diseases.

Absence of viremia in primary herpetic gingivostomatitis.

S. Halperin, J. Hendley, Z. Shehab, 1983, Pediatric infectious disease.

Safety and immunogenicity of 2010–2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine

O. Vanderkooi, S. Halperin, B. Ward, 2013, Human vaccines & immunotherapeutics.

Reduced susceptibility to penicillin among pneumococci causing invasive infection in children - Canada, 1991 to 1998.

E. Wang, L. Pelletier, S. Halperin, 2001, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

The reemergence of pertussis and infant deaths: is it time to immunize pregnant women?

S. Halperin, B. Halperin, 2011, Future microbiology.

Immunization in pregnancy

A. Gruslin, S. Halperin, D. Money, 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Immunization in pregnancy.

A. Gruslin, S. Halperin, D. Money, 2008, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review.

S. Deeks, N. Crowcroft, S. Halperin, 2018, Vaccine.

Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: interim analysis.

O. Vanderkooi, S. Halperin, J. Bettinger, 2012, Vaccine.

Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine.

J. Langley, S. Halperin, B. Eastwood, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunization in Canada: Update for 2015.

S. Halperin, D. Macdougall, D. MacDougall, 2016, The Journal of the Canadian Chiropractic Association.

Healthcare provider awareness, attitudes, beliefs, and behaviors regarding the role of pharmacists as immunizers

S. Halperin, J. Isenor, D. Halperin, 2022, Human vaccines & immunotherapeutics.

Vaccine regulation should require and enforce the inclusion of pregnant and breastfeeding women in prelicensure clinical trials

J. Langley, E. McClymont, S. Halperin, 2022, Human vaccines & immunotherapeutics.

Mutation of the Thiol-Disulfide Oxidoreductase SdbA Activates the CiaRH Two-Component System, Leading to Bacteriocin Expression Shutdown in Streptococcus gordonii

S. Halperin, L. Davey, Song F Lee, 2015, Journal of bacteriology.

Research involving pregnant women: trials and tribulations

F. Baylis, S. Halperin, 2012 .

Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.

Michael W. Dzierlenga, M. Longnecker, Shinichi Nakagawa, 2023, Environment international.

Expression of a Functional Single-Chain Variable-Fragment Antibody against Complement Receptor 1 in Streptococcus gordonii

S. Halperin, Song F Lee, K. A. West, 2008, Clinical and Vaccine Immunology.

Critical Role of the Interleukin-17/Interleukin-17 Receptor Axis in Regulating Host Susceptibility to Respiratory Infection with Chlamydia Species

J. Kolls, S. Halperin, Jun Wang, 2009, Infection and Immunity.

Long term therapy of cytomegalovirus retinitis with ganciclovir in a child with acquired immunodeficiency syndrome.

S. Halperin, G. L. La Roche, 1993, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

COVID-19 in children: the link in the transmission chain

S. Halperin, A. Kelvin, 2020, The Lancet Infectious Diseases.

Successful Treatment of Massive Anogenital Warts in a Two-Year-Old Boy With Imiquimod and Cimetidine Immunotherapy

V. Waters, S. Halperin, S. Richardson, 2009 .

Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.

Y. Lau, S. Halperin, Li-Min Huang, 2022, Vaccine.

Gemella species endocarditis in a child.

S. Halperin, J. Finley, M. Lovgren, 2001, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

J. Langley, K. Ford, Ly-Mee Yu, 2008, JAMA.

Failure of physicians to consider the diagnosis of pertussis in children.

S. Deeks, S. Halperin, P. Déry, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine

J. Langley, S. Halperin, B. Ward, 2013, Human vaccines & immunotherapeutics.

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age.

J. Langley, S. Halperin, B. Ward, 2012, Vaccine.

Construction and Characterization of a Single-Chain Variable Fragment Antibody Library against Fusobacterium nucleatum

Yung-Hua Li, S. Halperin, S. Bearne, 2012 .

Pertussis: Biology, epidemiology and prevention.

K. Mills, S. Halperin, S. Plotkin, 2016, Vaccine.

The changing and dynamic epidemiology of meningococcal disease.

L. Harrison, B. Greenwood, S. Ladhani, 2012, Vaccine.

History of penicillin allergy and referral for skin testing: evaluation of a pediatric penicillin allergy testing program.

J. Langley, S. Halperin, R. Bortolussi, 2002, Clinical and investigative medicine. Medecine clinique et experimentale.

Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.

L. Babiuk, R. Hancock, A. Potter, 2011, Vaccine.

Response to the changing epidemiology of meningococcal disease in North America 1945-2010

S. Halperin, J. Bettinger, D. Scheifele, 2013, Human vaccines & immunotherapeutics.

Parental willingness to enter a child in a controlled vaccine trial.

J. Langley, S. Halperin, E. Mills, 1998, Clinical and investigative medicine. Medecine clinique et experimentale.

POSTVACCINATION THROMBOCYTOPENIA IN CANADA

S. Halperin, J. Bettinger, L. Sauvé, 2010, The Pediatric infectious disease journal.

Oculoglandular Syndrome Caused by Francisella tularensis

S. Halperin, P. Ferrieri, T. Gast, 1985, Clinical pediatrics.

Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Harry Seifert, S. Halperin, A. Taddio, 2012, Vaccine.

Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data.

E. Rothstein, W. Walop, S. Halperin, 2007, Vaccine.

Thrombocytopenia after immunization of Canadian children, 1992 to 2001

S. Halperin, D. Scheifele, T. Jadavji, 2003, The Pediatric infectious disease journal.

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant.

S. Halperin, Bruce Smith, J. Eiden, 2003, Vaccine.

Bacterial tracheitis associated with respiratory syncytial virus infection and toxic shock syndrome.

S. Halperin, C. Nijssen-Jordan, J. D. Donaldson, 1990, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Measles Antibody Levels in Young Infants

S. Deeks, N. Crowcroft, T. Mazzulli, 2019, Pediatrics.

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People

S. Trottier, M. Loeb, A. Chit, 2017, The Journal of infectious diseases.

Reducing pain during vaccine injections: clinical practice guideline

C. Chambers, M. Antony, E. Lang, 2015, Canadian Medical Association Journal.

Pertussis vaccines: where to now?

S. Halperin, J. Poolman, H. Hallander, 2011, Expert review of vaccines.

A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age

J. Langley, J. Cailhier, P. Savard, 2020, Vaccines.

Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture.

S. Halperin, B. Eastwood, A. C. Nestruck, 1998, Vaccine.

Exposure-based Interventions for the management of individuals with high levels of needle fear across the lifespan: a clinical practice guideline and call for further research

C. Chambers, M. Antony, E. Lang, 2016, Cognitive behaviour therapy.

Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants.

S. Halperin, H. Davies, B. Eastwood, 1997, The Journal of pediatrics.

Comparative Evaluation of Safety and Immunogenicity of Two Dosages of an Oral Live Attenuated Human Rotavirus Vaccine

R. Ward, S. Halperin, B. Innis, 2005, The Pediatric infectious disease journal.

The effect of the COVID-19 pandemic on influenza-related hospitalization, intensive care admission and mortality in children in Canada: A population-based study

C. Bancej, S. Halperin, K. Top, 2021, The Lancet Regional Health - Americas.

Molecular characterization of rotavirus isolates from select Canadian pediatric hospitals

S. Halperin, J. Bettinger, T. Booth, 2012, BMC Infectious Diseases.

Toll‐like receptor 3 blockade in rhinovirus‐induced experimental asthma exacerbations: A randomized controlled study

V. Backer, S. Johnston, B. Lipworth, 2017, The Journal of allergy and clinical immunology.

Prenatal Screening for HIV in Nova Scotia: Survey of Postpartum Women and Audit of Current Prenatal Screening Practices.

S. Halperin, Bruce Smith, H. Scott, 2006, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Functional Analysis of Paralogous Thiol-disulfide Oxidoreductases in Streptococcus gordonii*

S. Halperin, L. Davey, Song F Lee, 2013, The Journal of Biological Chemistry.

Identification of a Thiol-Disulfide Oxidoreductase (SdbA) Catalyzing Disulfide Bond Formation in the Superantigen SpeA in Streptococcus pyogenes

S. Halperin, Song F Lee, Lydia Li, 2021, Journal of bacteriology.

Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline

C. Chambers, M. Rieder, V. Palda, 2010, Canadian Medical Association Journal.

Synergistic BM-DC activation and immune induction by the oral vaccine vector Streptococcus gordonii and exogenous tumor necrosis factor.

A. Stadnyk, S. Halperin, Song F Lee, 2009, Molecular immunology.

Hepatitis A and travel amongst Nova Scotia postsecondary students: evidence for a targeted vs. universal immunization strategy.

J. Langley, S. Halperin, S. Mcneil, 2010, Vaccine.

Immunization practices in acute lymphocytic leukemia and post-hematopoietic stem cell transplant in Canadian Pediatric Hematology/Oncology centers

S. Halperin, K. Top, G. De Serres, 2016, Human vaccines & immunotherapeutics.

Invasive Haemophilus Influenzae Type B Infections in Children with Cancer in the Era of Infant HIB Immunization Programs (1991–2014): A Report From the Canadian Immunization Monitoring Program Active

S. Halperin, K. Top, J. Bettinger, 2017, The Pediatric infectious disease journal.

Vaccination Against Influenza in Pregnancy: A Survey of Canadian Maternity Care Providers.

Devon L. Greyson, H. Witteman, K. Wilson, 2019, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Re-vaccination and adverse event recurrence in patients with adverse events following immunization.

F. Noya, S. Halperin, K. Top, 2022, The Journal of pediatrics.

Pertussis of adults and infants.

S. Halperin, N. Guiso, N Guiso, 2002, The Lancet. Infectious diseases.

Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases.

L. Pelletier, S. Halperin, J. Bettinger, 2010, Vaccine.

Pertussis is a frequent cause of prolonged cough illness in adults and adolescents.

S. Halperin, J. Spika, Bruce Smith, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Case-control study of household contacts to examine immunological protection from Bordetella pertussis transmission - study protocol.

O. Vanderkooi, L. Hoang, A. Rebbapragada, 2017, CMAJ open.

Expert Review of Vaccines

S. Deeks, S. Halperin, J. Bettinger, 2013 .

CD4+CD25+Foxp3+ Regulatory T Cells Promote Th17 Responses and Genital Tract Inflammation upon Intracellular Chlamydia muridarum Infection

S. Halperin, Jun Wang, J. Moore-Connors, 2013, The Journal of Immunology.

High Level Antibody Avidity is Achieved in HIV-Seropositive Recipients of an Inactivated Split Adjuvanted (AS03A) Influenza Vaccine

S. Walmsley, S. Halperin, B. Ward, 2014, Journal of Clinical Immunology.

Health Outcomes in Young Children Following Pertussis Vaccination During Pregnancy

K. Wilson, S. Hawken, N. Crowcroft, 2021, Pediatrics.

Use of lidocaine-prilocaine patch to decrease intramuscular injection pain does not adversely affect the antibody response to diphtheria-tetanus-acellular pertussis-inactivated poliovirus -Haemophilus influenzae type b conjugate and hepatitis B vaccines in infants from birth to six months of age

P. McGrath, S. Halperin, Bruce Smith, 2002, The Pediatric infectious disease journal.

Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response.

P. McGrath, S. Halperin, Bruce Smith, 2000, The Journal of pediatrics.

Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline (summary)

C. Chambers, M. Rieder, V. Palda, 2010, Canadian Medical Association Journal.

Transmission of Bordetella pertussis to Young Infants

Aaron M. Wendelboe, David Greenberg, Annelies Van Rie, 2007, The Pediatric infectious disease journal.

Changing epidemiology and emerging risk groups for pertussis

S. Halperin, E. Galanis, A. King, 2006, Canadian Medical Association Journal.

232 – Bordetella pertussis

V. Waters, S. Halperin, 2015 .

Knowledge, attitudes, beliefs, and behaviors of parents and healthcare providers before and after implementation of a universal rotavirus vaccination program.

J. Langley, S. Halperin, D. Macdougall, 2016, Vaccine.

Has the change to acellular pertussis vaccine improved or worsened pertussis control?

S. Halperin, G. De Serres, 2006, Canadian Medical Association Journal.

Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.

J. Langley, S. Halperin, F. Boucher, 2004, Pediatrics.

A Randomized, Placebo-Controlled Trial of Erythromycin Estolate Chemoprophylaxis for Household Contacts of Children With Culture-Positive Bordetella pertussis Infection

J. Langley, B. Eastwood, S. Halperin, 1999, Pediatrics.

Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections.

J. Langley, B. Eastwood, S. Halperin, 1997, Pediatrics.

Pertussis vaccination in pregnancy in Canada: a cost-utility analysis.

D. Coyle, S. Halperin, M. Sadarangani, 2020, CMAJ open.

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

K. Reisinger, J. Langley, S. Halperin, 2013, The Journal of infectious diseases.

Improved Efficacy of a Licensed Acellular Pertussis Vaccine, Reformulated in an Adjuvant Emulsion of Liposomes in Oil, in a Murine Model

S. Halperin, M. Mansour, Bruce Smith, 2007, Clinical and Vaccine Immunology.

Acellular pertussis vaccines: the next step.

S. Halperin, 1997, Developments in biological standardization.

Acellular vaccines for preventing whooping cough in children.

S. Halperin, Linjie Zhang, S. Prietsch, 2011, The Cochrane database of systematic reviews.

Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population.

P Duclos, S. Halperin, P. Duclos, 1997, Vaccine.

New Challenges for Pertussis Vaccines

S. Halperin, 2016 .

Pertussis: A Global Perspective.

S. Halperin, 2014, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Development of a gene delivery system in Streptococcus gordonii using thymidylate synthase as a selection marker.

S. Halperin, Song F Lee, Maram Hulbah, 2016, Journal of microbiological methods.

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

J. Langley, P. Cahn, Wei Chen, 2021, The Lancet.

Comparison of Children Hospitalized With Seasonal Versus Pandemic Influenza A, 2004–2009

S. Halperin, J. Bettinger, D. Tran, 2012, Pediatrics.

Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012–2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial

J. Langley, Ping Li, S. Halperin, 2014, Journal of the Pediatric Infectious Diseases Society.

Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.

O. Vanderkooi, S. Kuhn, J. Langley, 2012, Vaccine.

A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity.

L. Babiuk, R. Hancock, V. Gerdts, 2009, Vaccine.

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.

J. Langley, S. Halperin, S. Mcneil, 2006, Vaccine.

A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine.

J. Langley, S. Halperin, A. Taddio, 2012, Vaccine.

Overcoming codon-usage bias in heterologous protein expression in Streptococcus gordonii.

Yi-jing Li, S. Halperin, Song F Lee, 2009, Microbiology.

Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation

M. Loeb, S. Halperin, J. Bettinger, 2014, BMC Public Health.

Proceedings of the Canadian Association for HIV Research: Canadian Foundation for Infectious Diseases Professional Development Workshop for Viral Researchers.

Trushar R. Patel, S. Halperin, G. van Marle, 2019, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.

Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impact.

D. Skowronski, S. Halperin, D. Patrick, 2003, Pediatrics.

Pertussis Epidemic and Sudden Infant Death Syndrome

S. Halperin, M. Jan, 1998, Clinical pediatrics.

Improving rates of maternal immunization: Challenges and opportunities

S. Halperin, D. Macdougall, D. MacDougall, 2016, Human vaccines & immunotherapeutics.

Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults.

J. Langley, S. Halperin, W. Heyward, 2012, Vaccine.

Comparison of parental and health care professional preferences for the acellular or whole cell pertussis vaccine.

B. Eastwood, S. Halperin, B. Eastwood, 1998, The Pediatric infectious disease journal.

Maintaining the momentum: Key factors influencing acceptance of influenza vaccination among pregnant women following the H1N1 pandemic

S. Halperin, S. Mcneil, D. MacKinnon-Cameron, 2014, Human vaccines & immunotherapeutics.

Impact of Frailty on Influenza Vaccine Effectiveness and Clinical Outcomes: Experience from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network 2011/12 Season

S. Trottier, M. Loeb, B. Light, 2016 .

Outcomes of immunocompromised children hospitalized for influenza, 2010-2021, the Canadian Immunization Monitoring program active (IMPACT).

C. Bancej, S. Halperin, K. Top, 2023, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Evaluation of a tuberculosis screening program at a children's hospital.

J. Langley, S. Halperin, 1992, American journal of infection control.

Elevated Inflammatory Mediators in Adults with Oculorespiratory Syndrome following Influenza Immunization: a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study

J. Langley, S. Halperin, J. Bettinger, 2013, Clinical and Vaccine Immunology.

, Network Study Health Research Influenza Research Agency of Canada / Canadian Institutes of Influenza Immunization : a Public Health with Oculorespiratory Syndrome following Elevated Inflammatory Mediators in Adults

J. Langley, S. Halperin, M. Al-Dabbagh, 2013 .

Current Immunization Practices and Their Effects on Young Childrens (Birth to Five Years) Social and Emotional Development

S. Halperin, 2004 .

Safety and Immunogenicity of a Toddler Dose Following an Infant Series of a Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae type b, Hepatitis B Vaccine Administered Concurrently or at Separate Visits With a Heptavalent Pneumococcal Conjugate Vaccin

S. Halperin, A. Tomovici, M. Dionne, 2013, The Pediatric infectious disease journal.

Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age.

S. Halperin, F. Diaz-Mitoma, D. Radley, 2011, Vaccine.

Influenza Vaccine Effectiveness in the Prevention of Influenza-Related Hospitalization in Canadian Adults Over the 2011/12 Through 2013/14 Season: A Pooled Analysis From the Serious Outcomes Surveillance (SOS) Network of the Canadian Influenza Research Network (CIRN)

S. Trottier, M. Loeb, B. Light, 2016 .

The role of healthcare provider attitudes in increasing willingness to accept seasonal influenza vaccine policy changes.

Steven M. Smith, J. Slaunwhite, J. Langley, 2016, Vaccine.

Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program.

J. Langley, S. Halperin, K. Top, 2017, Vaccine.

Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study.

J. Langley, S. Halperin, K. Top, 2016, Vaccine.

Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.

M. Gold, S. Halperin, U. Heininger, 2004, Vaccine.

Hypotonic-hyporesponsive episodes in children hospitalized at 10 Canadian Pediatric Tertiary-Care Centres, 1991-1994.

S. Halperin, P. Déry, R. Gold, 1997, Canada communicable disease report = Releve des maladies transmissibles au Canada.

DNA fingerprinting in investigation of apparent nosocomial acquisition of neonatal herpes simplex.

B. Roizman, S. Halperin, J. Hendley, 1980, The Journal of pediatrics.

Pharmacological and Combined Interventions to Reduce Vaccine Injection Pain in Children and Adults

C. Chambers, S. Halperin, R. P. Pillai Riddell, 2015, The Clinical journal of pain.

Challenges to immunization: the experiences of homeless youth

S. Halperin, N. MacDonald, J. Graham, 2012, BMC Public Health.

IMPACT monitoring network: A better mousetrap.

S. Halperin, P. Déry, R. Gold, 1993, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Vaccination during pregnancy: Canadian maternity care providers' opinions and practices

Devon L. Greyson, H. Witteman, K. Wilson, 2020, Human vaccines & immunotherapeutics.

Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine

D. Granoff, S. Halperin, N. MacDonald, 2000 .

J. Langley, S. Halperin, B. Ward, 2012 .

The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis

A. M. Kazi, S. Omer, J. Langley, 2021, Vaccine.

Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin.

S. Halperin, T. Issekutz, A. Kasina, 1991, The Journal of infectious diseases.

Strategies for successful rapid trials of influenza vaccine

J. Langley, S. Halperin, D. Scheifele, 2011, Clinical trials.

Polymorphisms of the Fimbria fim3 Gene of Bordetella pertussis Strains Isolated in Canada

P. V. Van Caeseele, I. Martin, S. Halperin, 2004, Journal of Clinical Microbiology.

A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

E. Rothstein, W. Walop, S. Halperin, 2008, Vaccine.

Immunizing Patients With Adverse Events After Immunization and Potential Contraindications to Immunization: A Report From the Special Immunization Clinics Network

S. Halperin, K. Top, C. Quach, 2016, The Pediatric infectious disease journal.

The Canadian Immunization Monitoring Program, ACTive (IMPACT): Active surveillance for vaccine adverse events and vaccine-preventable diseases.

S. Halperin, J. Bettinger, D. Scheifele, 2014, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Do Dose Numbers Matter?: Evaluation of Differing Infant and Toddler Meningococcal C Conjugate Vaccine Programs in Canadian Children

O. Vanderkooi, S. Halperin, J. Bettinger, 2016, The Pediatric infectious disease journal.

Compliance with recommendations for routine HIV screening during pregnancy in Halifax.

S. Halperin, S. Côté, 2002, Paediatrics & child health.

High-Level Immunogenicity Is Achieved Vaccine With Adjuvanted Pandemic H1N12009 and Improved With Booster Dosing in a Randomized Trial of HIV-Infected Adults

S. Walmsley, S. Halperin, C. Cooper, 2012, HIV clinical trials.

The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak.

S. Halperin, E. Talbot, K. Broder, 2010, Vaccine.

Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What the Canadian public knows and wants to know.

J. Langley, S. Halperin, D. Macdougall, 2015, Vaccine.

Effectiveness of a single dose of acellular pertussis vaccine to prevent pertussis in children primed with pertussis whole cell vaccine.

S. Halperin, G. De Serres, N. Boulianne, 2001, Vaccine.

Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.

K. Reisinger, S. Halperin, H. Keyserling, 1995, Scandinavian journal of infectious diseases.

Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015

O. Vanderkooi, S. Halperin, K. Top, 2018, Journal of the Pediatric Infectious Diseases Society.

Trivalent MDCK cell culture- derived influenza vaccine

S. Halperin, A. Doroshenko, 2009 .

Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial.

O. Vanderkooi, G. Zuccotti, F. Martinón-Torres, 2019, Vaccine.

Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults.

J. Langley, S. Halperin, A. Kimura, 2007, Vaccine.

Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose

D. Bernstein, M. Decker, M. Hall, 2018, Journal of the Pediatric Infectious Diseases Society.

Obstetric and perinatal health outcomes after pertussis vaccination during pregnancy in Ontario, Canada: a retrospective cohort study

K. Wilson, S. Hawken, N. Crowcroft, 2021, CMAJ open.

From soap and water, to waterless agents: Update on hand hygiene in healthcare settings.

H. Davies, J. Langley, S. Halperin, 2002, Paediatrics & child health.

Implementation of a universal rotavirus vaccination program: comparison of two delivery systems

J. Langley, C. Sanford, Mitchell Zelman, 2014, BMC Public Health.

Canadian vaccine research networks: Vaccine safety resources for Canada.

J. Langley, S. Deeks, N. Crowcroft, 2015, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers.

J. Langley, S. Halperin, A. McGeer, 2015, Vaccine.

Serological correlates of immunity to Bordetella pertussis.

E. Hewlett, S. Halperin, 1998, Vaccine.

Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life.

S. Halperin, B. Eastwood, L. Barreto, 1996, Vaccine.

Against vaccine assay secrecy

J. Langley, S. Halperin, M. Herder, 2015, Human vaccines & immunotherapeutics.

Developing better paediatric vaccines: the case of pertussis vaccine.

S. Halperin, 1999, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD

S. Trottier, M. Loeb, A. Chit, 2019, Chest.

Lyme disease in Canada: Q & A for paediatricians.

S. Halperin, B. Lang, 2009, Paediatrics & child health.

Evaluation of the effectiveness of maternal immunization against pertussis in Alberta using agent-based modeling: A Canadian immunization research network study.

P. Rohani, N. Osgood, D. Fisman, 2023, Vaccine.

Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin.

M. Dhalla, R. Malley, G. Siber, 1999, The Pediatric infectious disease journal.

A pilot study to quantify parental anxiety associated with enrollment of an infant or toddler in a phase III vaccine trial.

J. Langley, S. Halperin, Bruce Smith, 2003, Vaccine.

Knowledge, attitudes, behaviours, and beliefs of healthcare provider students regarding mandatory influenza vaccination

S. Halperin, J. Isenor, D. Halperin, 2019, Human vaccines & immunotherapeutics.

Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age.

S. Halperin, E. Mills, B. Eastwood, 1995, The Pediatric infectious disease journal.

Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT).

L. Pelletier, S. Halperin, J. Talbot, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine?

D. Granoff, S. Halperin, N. MacDonald, 2000, Journal of the American Medical Association (JAMA).

Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine.

Bruce Smith, Luis Barreto, Roland Guasparini, 2003, Vaccine.

Impact of vaccination during pregnancy on infants’ immune responses to vaccinations- definitions and statistical approaches

S. Halperin, M. Sadarangani, N. Curtis, 2022, Vaccine.

Cost-Effectiveness Analysis of Nirsevimab and RSVpreF Vaccine Prevention Strategies for Respiratory Syncytial Virus Disease: A Canadian Immunisation Research Network (CIRN) Study

A. Galvani, S. Moghadas, J. Langley, 2023, medRxiv.

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults

S. Trottier, M. Loeb, A. Chit, 2019, Journal of medical microbiology.

Pathogenesis of lower respiratory tract symptoms in experimental rhinovirus infection.

P. Suratt, S. Halperin, J. Hendley, 1983, The American review of respiratory disease.

A muti-informant national survey on the impact of COVID-19 on mental health symptoms of parent–child dyads in Canada

E. McArthur, K. Birnie, S. Halperin, 2023, Scientific reports.

Canadian Association for Immunization Research and Evaluation (CAIRE) Guidelines for Industry Sponsored Clinical Trial and Epidemiology Contract Research

D. Skowronski, S. Halperin, Brian Ward, 2005, Human vaccines.

Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness

S. Trottier, M. Loeb, J. Langley, 2023, Open forum infectious diseases.

Assuring vaccine safety: A celebration of 10 years of progress with the IMPACT project.

S. Halperin, A. King, R. Gold, 2002, Paediatrics & child health.

Identifying and addressing the impacts of the COVID-19 pandemic on school-based immunisation programmes in the Canadian Maritimes: a mixed methods study protocol

S. Halperin, J. Parsons Leigh, J. Curran, 2023, BMJ Open.

Immunoblotting conditions for small peptides from streptococci.

S. Halperin, L. Davey, Song F Lee, 2015, Journal of microbiological methods.

Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

E. Rothstein, W. Walop, S. Halperin, 2007, Vaccine.

Prolonged survival of Bordetella pertussis in a simple buffer after nasopharyngeal secretion aspiration.

S. Halperin, A. Kasina, M. Swift, 1992, Canadian journal of microbiology.

Clinical course of pertussis in immunized children

S. Halperin, R. Bortolussi, B. Miller, 1995, The Pediatric infectious disease journal.

Construction and Characterization of a Single-Chain Variable Fragment Antibody Library against Fusobacterium nucleatum

Yung-Hua Li, S. Halperin, S. Bearne, 2012 .

Immune Responses to Pertussis Vaccines Concurrently Administered with Viral Vaccines

J. Langley, B. Eastwood, S. Halperin, 1995, Annals of the New York Academy of Sciences.

The Hidden Costs and Characteristics of Childhood Rotavirus Emergency Visits in Canada

D. Coyle, S. Halperin, J. Bettinger, 2012, The Pediatric infectious disease journal.

Clinical Presentations and Outcomes of Children in Canada With Recurrent Invasive Pneumococcal Disease From the IMPACT Surveillance Network

O. Vanderkooi, W. Demczuk, I. Martin, 2022, The Pediatric Infectious Disease Journal.

Public awareness, attitudes, beliefs, and behaviors regarding the role of pharmacists as immunizers

S. Halperin, J. Isenor, D. Halperin, 2021, Human vaccines & immunotherapeutics.

Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.

L. Babiuk, R. Hancock, A. Potter, 2011, Vaccine.

Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impact.

D. Skowronski, S. Halperin, D. Patrick, 2003, Pediatrics.

Historic low Haemophilus influenzae type B case tally--Canada 2000.

S. Halperin, P. Déry, J. Embree, 2001, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Lack of Evidence of Encephalopathy Related to Pertussis Vaccine : Active Surveillance by IMPACT, Canada, 1993–2002

S. Halperin, D. Moore, M. Yoshinaga, 2004, The Pediatric infectious disease journal.

Pertussis encephalopathy in an adult: case report and review.

S. Halperin, T. Marrie, S. Halperin, 1991, Reviews of infectious diseases.

Improving rates of maternal immunization: Challenges and opportunities

S. Halperin, D. MacDougall, 2016, Human vaccines & immunotherapeutics.

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

J. Singer, Dianne Miller, J. Langley, 2013, JAMA.

The changing and dynamic epidemiology of meningococcal disease.

L. Harrison, B. Greenwood, S. Ladhani, 2012, Vaccine.

Codesigning a user-centred digital psychoeducational tool for youth mental well-being with families in Canada: study protocol for a sequential exploratory mixed methods study

H. Stelfox, K. Birnie, S. Halperin, 2023, BMJ Open.

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

J. Langley, K. Ford, Ly-Mee Yu, 2008, JAMA.

ImmunogenicityofaTetravalentMeningococcal Glycoconjugate Vaccine in Infants

J. Langley, K. Ford, A. Pollard, 2006 .

Overcoming codon-usage bias in heterologous protein expression in Streptococcus gordonii.

Yi-jing Li, S. Halperin, Song F Lee, 2009, Microbiology.

Cellular Immunity as a Potential Cause of Local Reactions to Booster Vaccination With Diphtheria and Tetanus Toxoids and Acellular Pertussis Antigens

S. Halperin, D. Scheifele, J. Ochnio, 2009, The Pediatric infectious disease journal.

Immunization in Canada: a 6-year update.

S. Halperin, K. Pianosi, 2010, The Journal of the Canadian Chiropractic Association.

Implementation Effectiveness of a Parent-Directed YouTube Video (“It Doesn’t Have To Hurt”) on Evidence-Based Strategies to Manage Needle Pain: Descriptive Survey Study

C. Chambers, K. Birnie, S. Halperin, 2019, JMIR pediatrics and parenting.

The Hidden Costs and Characteristics of Childhood Rotavirus Emergency Visits in Canada

D. Coyle, S. Halperin, J. Bettinger, 2012, The Pediatric infectious disease journal.

[Immunization in pregnancy].

A. Gruslin, S. Halperin, D. Money, 2008, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Toward more specific and transparent research and development costs: the case of seasonal influenza vaccines.

A. Chit, P. Grootendorst, M. Krahn, 2014, Vaccine.